🗞️ Why in News The Hindu published an editorial arguing that the Union Budget 2026-27 allocation increase for AYUSH and the India-EU Free Trade Agreement provisions represent a pivotal moment for Ayurveda, but success requires rigorous scientific validation rather than cultural assertion alone.
The AYUSH Moment
India’s AYUSH sector — Ayurveda, Yoga, Unani, Siddha, and Homeopathy — is at a strategic inflection point:
| Development | Detail |
|---|---|
| AYUSH Ministry budget 2026-27 | Rs 4,408 crore (nearly doubled in 5 years) |
| New institutions | 3 new All India Institutes of Ayurveda announced |
| India-EU FTA | Enables cross-border AYUSH service provision in Europe |
| Global market | AYUSH exports growing at ~20% annually |
The Editorial’s Core Argument
While welcoming the budgetary push and trade opportunities, the editorial raises critical concerns:
-
Scientific validation gap — Many AYUSH formulations lack the rigorous clinical trial evidence that global markets demand. Without evidence-based validation, India risks legal disputes and reputational damage.
-
Conflict of interest in research — Much AYUSH research is conducted by institutions that are simultaneously promotional bodies. This creates credibility concerns in international scientific circles.
-
Complementary, not competing — Ayurveda and biomedicine operate from fundamentally different conceptual frameworks (doshas vs pathology). The editorial argues they should complement rather than compete — “evidence-based validation strengthens rather than threatens traditional systems.”
-
Regulatory gaps — India’s AYUSH regulatory framework (under the Drugs and Cosmetics Act) is less stringent than allopathic drug regulation. This inconsistency weakens global acceptance.
AYUSH in India — Key Data
| Parameter | Data |
|---|---|
| AYUSH Ministry | Established 2014 (upgraded from Department) |
| AYUSH hospitals | ~4,000 (public + private) |
| Registered practitioners | ~8 lakh |
| AYUSH exports | ~Rs 10,000 crore (2024-25) |
| Key export markets | US, EU, Japan, Southeast Asia |
| WHO Traditional Medicine Strategy | 2014-2023 (extended) |
India-EU FTA and AYUSH
The India-EU Free Trade Agreement, signed in 2025, includes specific provisions for AYUSH services:
- Mutual recognition of practitioner qualifications (in progress)
- Market access for AYUSH products meeting EU safety standards
- Provisions for cross-border telehealth consultations in Ayurveda
- Reduced tariffs on herbal and Ayurvedic formulations
This represents India’s first major FTA to explicitly include traditional medicine services.
Global Traditional Medicine Landscape
| Country | System | Global Reach |
|---|---|---|
| India | Ayurveda, Yoga | Growing global presence |
| China | Traditional Chinese Medicine (TCM) | WHO-integrated, 196 countries |
| Japan | Kampo Medicine | Insurance-covered domestic |
| South Korea | Korean Medicine | Government-regulated |
China’s success with TCM — now integrated into WHO classifications (ICD-11) — provides both a model and a competitive benchmark for India’s AYUSH ambitions.
Way Forward
- Independent validation bodies — Separate research from promotion by establishing autonomous AYUSH research councils
- Pharmacovigilance — Strengthen adverse event reporting for AYUSH products
- Standardisation — Develop internationally recognised quality standards for AYUSH formulations
- Integration — Follow the Kerala model of co-locating AYUSH and allopathic departments in district hospitals
UPSC Relevance
Prelims: AYUSH Ministry (est. 2014), India-EU FTA AYUSH provisions, WHO Traditional Medicine Strategy, ICD-11. Mains GS-2: Health governance — integrating traditional medicine into public healthcare; India-EU FTA and services trade. Mains GS-3: AYUSH as an export opportunity; balancing traditional knowledge with scientific evidence.
📌 Facts Corner — Knowledgepedia
AYUSH Ministry:
- Full form: Ayurveda, Yoga & Naturopathy, Unani, Siddha, Homeopathy
- Established: November 9, 2014 (upgraded from Department of AYUSH under Health Ministry)
- Current Minister: Ministry of AYUSH, Government of India
- Budget 2026-27: Rs 4,408 crore
India-EU FTA:
- Negotiations began: 2007 (relaunched 2022)
- Signed: 2025
- AYUSH provisions: First Indian FTA to include traditional medicine services
- Covers: Goods, services, investment, digital trade
Key AYUSH Institutions:
- AIIA: All India Institute of Ayurveda (New Delhi, est. 2016)
- CCRAS: Central Council for Research in Ayurvedic Sciences
- National AYUSH Mission (NAM): launched 2014 for AYUSH infrastructure development
WHO and Traditional Medicine:
- WHO Traditional Medicine Strategy: 2014-2023 (extended)
- ICD-11 (2019): First to include Traditional Chinese Medicine classifications
- WHO Global Centre for Traditional Medicine: Jamnagar, Gujarat (India) — inaugurated 2022
Other Relevant Facts:
- India’s AYUSH exports: ~Rs 10,000 crore (2024-25)
- Registered AYUSH practitioners: ~8 lakh
- AYUSH hospitals: ~4,000
- Kerala: Pioneer in integrating Ayurveda with mainstream healthcare
Sources: The Hindu, Vajiram & Ravi